Literature DB >> 213743

Enkephalins and nigrostriatal function.

B I Diamond, R L Borison.   

Abstract

Unilateral lesions of the substantia nigra were made with 6-hydroxydopamine in rats. In this model, drugs such as naloxone, which block endogenous enkephalin receptors, potentiated agents with postsynaptic dopaminergic actions, while antagonizing agents with presynaptic dopaminergic actions. Drugs which increase brain enkephalin content (d-phenylalanine or methionine-enkephalin) antagonized postsynaptically active agents and potentiated presynaptic agents. Naloxone also reversed reserpine-induced parkinsonism in rats. Separate pre- and postsynaptic enkephalinergic neurons thus seem to modulate nigrostriatal function.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 213743     DOI: 10.1212/wnl.28.11.1805

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Enkephalin-induced myoclonic twitches blocked by ergometrine and potentiated by haloperidol.

Authors:  M R Dzoljic; A J van der Lely; J B von Mourik
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

2.  Presynaptic modulation of synaptic transmission by opioid receptor in rat subthalamic nucleus in vitro.

Authors:  Ke-Zhong Shen; Steven W Johnson
Journal:  J Physiol       Date:  2002-05-15       Impact factor: 5.182

3.  Effects of naloxone, metenkephalin, and morphine on phencyclidine-induced behavior in the rat.

Authors:  S Castellani; A J Giannini; P M Adams
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 4.  Neuropeptides in dopamine-containing regions of the brain.

Authors:  A Albanese; M C Altavista
Journal:  Ital J Neurol Sci       Date:  1984-12

5.  Enkephalin, morphine, and naloxone in tardive dyskinesia.

Authors:  N Bjørndal; D E Casey; J Gerlach
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.